Mariner, LLC Amgen Inc Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Amgen Inc stock. As of the latest transaction made, Mariner, LLC holds 895,130 shares of AMGN stock, worth $236 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

895,130

Previous 896,868 0.19%

Holding current value

$236 Million

Previous $280 Million 2.92%

% of portfolio

0.52%

Previous 0.55%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $537,702 - $586,366	-1,738 Reduced 0.19%	895,130 $288 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $12.5 Million - $15.2 Million	47,537 Added 5.6%	896,868 $280 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $17.7 Million - $21.4 Million	65,979 Added 8.42%	849,331 $241 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $11.6 Million - $13.1 Million	45,265 Added 6.13%	783,352 $226 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $23.8 Million - $29.6 Million	109,078 Added 17.34%	738,087 $198 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $52.9 Million - $62.6 Million	246,891 Added 64.61%	629,009 $140 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $33.8 Million - $41.2 Million	149,710 Added 64.42%	382,118 $92.4 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $3.62 Million - $4.6 Million	15,807 Added 7.3%	232,408 $61 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $1.45 Million - $1.63 Million	6,457 Added 3.07%	216,601 $48.8 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $578,159 - $643,390	-2,506 Reduced 1.18%	210,144 $51.1 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $13.1 Million - $14.5 Million	59,919 Added 39.23%	212,650 $51.4 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $15 Million - $17.2 Million	75,664 Added 98.18%	152,731 $34.4 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $3.85 Million - $4.52 Million	18,157 Added 30.82%	77,067 $16.4 Million
Q2 2021 Aug 24, 2021	BUY	$233.58 - $259.14 $1.89 Million - $2.09 Million	8,077 Added 15.89%	58,910 $14.4 Million
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $1.72 Million - $2 Million	-7,740 Reduced 13.21%	50,833 $12.6 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $1.37 Million - $1.63 Million	6,318 Added 12.09%	58,573 $13.5 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $204,614 - $227,548	872 Added 1.7%	52,255 $13.3 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $1.21 Million - $1.49 Million	6,131 Added 13.55%	51,383 $12.1 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $1.38 Million - $1.83 Million	7,574 Added 20.1%	45,252 $9.17 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $445,589 - $572,736	2,355 Added 6.67%	37,678 $9.08 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $1.82 Million - $2.18 Million	-10,453 Reduced 22.84%	35,323 $6.84 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $386,077 - $452,569	2,316 Added 5.33%	45,776 $8.44 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $7.62 Million - $8.59 Million	-42,152 Reduced 49.24%	43,460 $8.26 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $9.15 Million - $10.7 Million	51,296 Added 149.48%	85,612 $16.7 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $450,810 - $508,229	2,433 Added 7.63%	34,316 $7.11 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $2.66 Million - $2.99 Million	16,018 Added 100.96%	31,883 $5.89 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $2.21 Million - $2.58 Million	-13,017 Reduced 45.07%	15,865 $2.7 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $3.14 Million - $3.51 Million	18,630 Added 181.72%	28,882 $5.02 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $1.72 Million - $1.96 Million	10,252	10,252 $1.91 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account